Invesco
VRTX icon

Invesco’s Vertex Pharmaceuticals VRTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$883M Buy
1,984,046
+138,406
+7% +$61.6M 0.15% 137
2025
Q1
$895M Sell
1,845,640
-52,817
-3% -$25.6M 0.17% 120
2024
Q4
$765M Sell
1,898,457
-45,147
-2% -$18.2M 0.14% 149
2024
Q3
$904M Buy
1,943,604
+140,862
+8% +$65.5M 0.17% 115
2024
Q2
$845M Sell
1,802,742
-288,401
-14% -$135M 0.18% 105
2024
Q1
$874M Sell
2,091,143
-150,964
-7% -$63.1M 0.19% 102
2023
Q4
$912M Buy
2,242,107
+225,327
+11% +$91.7M 0.22% 84
2023
Q3
$701M Buy
2,016,780
+67,451
+3% +$23.5M 0.19% 108
2023
Q2
$686M Buy
1,949,329
+87,961
+5% +$31M 0.18% 112
2023
Q1
$586M Buy
1,861,368
+236,469
+15% +$74.5M 0.16% 138
2022
Q4
$469M Buy
1,624,899
+305,217
+23% +$88.1M 0.14% 180
2022
Q3
$382M Buy
1,319,682
+196,888
+18% +$57M 0.12% 203
2022
Q2
$316M Sell
1,122,794
-87,563
-7% -$24.7M 0.1% 274
2022
Q1
$316M Buy
1,210,357
+88,199
+8% +$23M 0.08% 339
2021
Q4
$246M Sell
1,122,158
-92,335
-8% -$20.3M 0.06% 438
2021
Q3
$220M Buy
1,214,493
+48,410
+4% +$8.78M 0.06% 447
2021
Q2
$235M Buy
1,166,083
+197,494
+20% +$39.8M 0.06% 450
2021
Q1
$208M Sell
968,589
-129,332
-12% -$27.8M 0.06% 454
2020
Q4
$259M Sell
1,097,921
-33,046
-3% -$7.81M 0.08% 336
2020
Q3
$308M Buy
1,130,967
+11,258
+1% +$3.06M 0.1% 228
2020
Q2
$325M Sell
1,119,709
-182,032
-14% -$52.8M 0.12% 202
2020
Q1
$310M Buy
1,301,741
+207,470
+19% +$49.4M 0.13% 182
2019
Q4
$240M Sell
1,094,271
-2,565,660
-70% -$562M 0.07% 337
2019
Q3
$620M Sell
3,659,931
-403,977
-10% -$68.4M 0.16% 135
2019
Q2
$745M Buy
4,063,908
+335,938
+9% +$61.6M 0.19% 102
2019
Q1
$686M Buy
3,727,970
+21,753
+0.6% +$4M 0.23% 88
2018
Q4
$614M Sell
3,706,217
-11,713
-0.3% -$1.94M 0.24% 87
2018
Q3
$717M Sell
3,717,930
-77,449
-2% -$14.9M 0.23% 94
2018
Q2
$645M Buy
3,795,379
+515,949
+16% +$87.7M 0.21% 100
2018
Q1
$534M Buy
3,279,430
+169,936
+5% +$27.7M 0.2% 118
2017
Q4
$466M Buy
3,109,494
+14,479
+0.5% +$2.17M 0.17% 136
2017
Q3
$471M Sell
3,095,015
-166,710
-5% -$25.3M 0.17% 138
2017
Q2
$420M Buy
3,261,725
+328,399
+11% +$42.3M 0.13% 168
2017
Q1
$321M Buy
2,933,326
+29,887
+1% +$3.27M 0.11% 217
2016
Q4
$214M Sell
2,903,439
-163,512
-5% -$12M 0.07% 289
2016
Q3
$267M Sell
3,066,951
-105
-0% -$9.16K 0.09% 245
2016
Q2
$264M Sell
3,067,056
-258,054
-8% -$22.2M 0.1% 232
2016
Q1
$264M Sell
3,325,110
-926,098
-22% -$73.6M 0.11% 216
2015
Q4
$535M Buy
4,251,208
+164,266
+4% +$20.7M 0.21% 98
2015
Q3
$426M Buy
4,086,942
+334,402
+9% +$34.8M 0.18% 118
2015
Q2
$463M Buy
3,752,540
+233,736
+7% +$28.9M 0.18% 124
2015
Q1
$415M Buy
3,518,804
+432,823
+14% +$51.1M 0.16% 142
2014
Q4
$367M Buy
3,085,981
+234,511
+8% +$27.9M 0.14% 165
2014
Q3
$320M Sell
2,851,470
-153,621
-5% -$17.3M 0.13% 189
2014
Q2
$285M Sell
3,005,091
-157,853
-5% -$14.9M 0.11% 217
2014
Q1
$224M Sell
3,162,944
-94,408
-3% -$6.68M 0.09% 270
2013
Q4
$242M Buy
3,257,352
+156,515
+5% +$11.6M 0.1% 254
2013
Q3
$235M Buy
3,100,837
+231,466
+8% +$17.5M 0.1% 232
2013
Q2
$230M Buy
+2,869,371
New +$230M 0.11% 215